Fennec Pharma Competitors and Similar CompaniesClear all
Fennec Pharma's competitors and similar companies include Urogen Pharma, LadRx and Rasna Therapeutics.
 Fennec Pharma Fennec Pharmaceuticals is a biotechnology company focused on the development of Sodium Thiosulfate for the prevention of ototoxicity from cisplatin in pediatric patients. |  LadRx LadRx Corporation (formerly known as CytRx Corporation) is a biopharmaceutical company focused on discovering, developing and commercializing new therapeutics to treat patients with cancer. |  Rasna Therapeutics Rasna Therapeutics focusses on development therapeutics to address the high unmet need that exists for AML and other forms of leukemia. | ||
Founding Date | Founding Date 1996 | Founding Date 2004 | Founding Date 1985 | Founding Date 2013 |
Type | Type Public | Type Public | Type Public | Type Public |
Tags | ||||
Locations | Locations US HQ | Locations New York, US HQ Tel Aviv Yafo, IL Princeton, US | Locations Los Angeles, US HQ | Locations New York, US HQ Greater London, GB Doylestown, US |
Employees | Employees 433% increase | Employees 194362% increase | Employees 385% decrease | Employees N/A |
Valuation ($) | Valuation ($) 129.4 m | Valuation ($) 515.9 m | Valuation ($) 901.1 k | Valuation ($) 3.1 m |
Financial | ||||
Revenue (est.) | Revenue (est.) $44.6m (FY, 2025) | Revenue (est.) $109.8m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income ($9.7m) (FY, 2025) | Net income ($153.5m) (FY, 2025) | Net income ($1.6m) (FY, 2024) | Net income ($4.4m) (FY, 2023) |
For sources of this data, please see the company profile
View Company Profiles
Urogen Pharma
HQ
New York, US
Employees
194
UroGen Pharma is a clinical-stage biopharmaceutical company.
View companyLadRx
HQ
Los Angeles, US
Employees
3
LadRx Corporation (formerly known as CytRx Corporation) is a biopharmaceutical company focused on discovering, developing and commercializing new therapeutics to treat patients with cancer.
View companyRasna Therapeutics
HQ
New York, US
Rasna Therapeutics focusses on development therapeutics to address the high unmet need that exists for AML and other forms of leukemia.
View company